BGPT: Paper Review: CRISPR/Cas‐mediated gene editing using purified protein in Drosophila suzukii

Explore by Goal

Quick Explanation Copied

Rigorous take

Kalajdzic & Schetelig show that injecting purified Cas9 protein + in vitro transcribed gRNAs into Drosophila suzukii embryos yields heritable, site-specific deletions in the X-linked white locus, recovering 13 nt and 3 nt deletions (Ex2Ex5, TRANS1-derived founders) and 1 nt frameshifting deletions (Ex5, TRANS1-derived founders). However, the intended EGFP knock-in via HDR was not recovered, and off-target assessment appears limited to a small candidate set.

Key evidence is quantitative (founder→G1 scoring) and molecular (sequenced deletion alleles), but mechanistic claims about HDR failure vs delivery/recombination constraints remain underdetermined.

Paper:

Long Explanation

Paper Review (visual first, then critique)

Target: X-linked D. suzukii white gene (eye-color marker) using purified recombinant Cas9 protein + in vitro transcribed gRNAs delivered by embryonic microinjection.

Observed outcome: heritable site-specific deletions in G1 mutants; no detectable EGFP knock-in via the provided HDR template.

1) Mutation spectrum across experiments (sequenced alleles)

Evidence basis: The paper reports eight G1 mutants with CRISPR-confirmed deletions: Ex2Ex5 includes two 13-nt deletion alleles and one 3-nt deletion allele; Ex5 includes five 1-nt deletion alleles (frameshift-truncating).

2) Founder→G1 germline transmission efficiency (what can/can’t be compared)

Important skeptical note: The authors explicitly state that exact germline transformation efficiency for Ex5 cannot be calculated because some G0 flies were mass-crossed; thus the Ex5 efficiency is a range.

3) HDR knock-in attempt vs observed PCR-confirmed integration

Direct report: The authors state that homologous recombination events were not detected in Ex5 and that an integrated EGFP cassette could not be detected (PCR).

4) Methodological strengths (what’s done well)

Protein-based Cas9 delivery is the study’s central test: purified Cas9 + in vitro transcribed gRNAs were injected into embryos, and heritability was assessed via a defined crossing scheme for an X-linked marker.
Molecular confirmation: the eye-color phenotypes were linked to white-locus deletions by PCR-amplified target-site sequencing, including detailed deletion-length reporting.
Off-target candidate testing was attempted: the authors identify predicted off-target genes and then sequence PCR amplicons for a set of candidate loci from mutants vs wild-type.

5) Critical appraisal (what is uncertain / potential blind spots)

A) HDR failure is reported, but the mechanism is not identified.

The paper states that homologous recombination and EGFP integration were not detected in Ex5.

What’s known: this design did not yield detectable integration in their assay.
What’s not known: whether failure is due to template architecture, repair kinetics in this embryo stage, chromatin context at the white exon 5 region, toxicity/handling effects, or assay sensitivity (e.g., whether junction PCRs and/or tissue sampling would miss mosaic or low-copy events). The paper does not provide alternative validation beyond the reported PCR check.

B) Eye-color phenotypes can be confounded by background, age, and screening subjectivity.

The authors discuss that brown/dark-red phenotypes in non-mutant G1 flies could arise from pleiotropic/epistatic effects of the female-specific lethal effector construct in the AH443 M11_f1 line, spontaneous white-locus loss-of-function alleles in stocks, and/or human subjective decisions in color intensity screening.

This matters because phenotypic scoring is used to decide which individuals proceed to sequencing. Even with sequencing confirmation for the final mutants, the intermediate filtering step could bias the mutation recovery spectrum (e.g., missing alleles with subtle phenotype changes).

C) Off-target assessment appears limited to a small candidate gene set (not whole-genome).

The paper reports sequencing of 18 predicted off-target genes’ candidate amplicons for two mutant deletion categories (13-nt and 1-nt) and reports no differences from wild-type at those loci.

What’s known: no detectable changes in the tested amplicons.
What’s uncertain: whether there are other off-target sites outside the candidate list, indels spanning larger regions, or low-frequency mosaic edits. Whole-genome or unbiased approaches are not described in the supplied text.

D) Transmission metrics are constrained by founder crossing design.

The authors provide a range for Ex5 due to mass-crossing of G0 flies. Even where exact calculations are possible (Ex2Ex5 TRANS1), the sample sizes are still small enough that uncertainty intervals would be informative—though none are provided in the text.

6) What the paper most convincingly demonstrates

Purified Cas9 protein can induce heritable, site-specific indels in D. suzukii at the intended white gRNA target sites, with recurrent deletion sizes observed among sequenced mutants.
At least one HDR knock-in configuration was not successful under the reported conditions/assays, despite producing knockout-like indels.

7) Interactive next steps inside BGPT

Author reviews

Feedback:

Updated: April 07, 2026